Accord Healthcare restarts production of cancer drug cisplatin amid shortages

The US Food and Drug Administration said Accord Healthcare has restarted production of the widely used cancer drug cisplatin amid ongoing drug shortages in the US.

Share This Post:

POPULAR POSTS
FOLLOW US
Like Us On Facebook
Follow Us On Twitter
Subscribe To Our Channel
TikTok
LIVE STREAM